Up a level |
Bourgeois, Stefan, Curescu, Manuela G, Larrey, Dominique G, Marra, Fiona ORCID: 0000-0003-1326-1149, Dorr, Patrick, Charafeddine, Mariem, Crown, Eric, Bondin, Mark and Back, David J
(2017)
Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study.
.
Ferenci, Peter, Bourgeois, Stefan, Buggisch, Peter, Norris, Suzanne, Curescu, Manuela, Larrey, Dominique, Marra, Fiona ORCID: 0000-0003-1326-1149, Kleine, Henning, Dorr, Patrick, Charafeddine, Mariem et al (show 4 more authors)
(2019)
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in hepatitis C virus genotype 1-and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
JOURNAL OF VIRAL HEPATITIS, 26 (6).
pp. 685-696.